Linical Co Ltd (2183)

Currency in JPY
339.0
0.0(0.00%)
Closed·
2183 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Earnings results expected in 7 days
High dividend Yield
2183 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
338.0340.0
52 wk Range
258.0416.0
Key Statistics
Bid/Ask
339.00 / 340.00
Prev. Close
339
Open
339
Day's Range
338-340
52 wk Range
258-416
Volume
4.8K
Average Volume (3m)
18.76K
1-Year Change
-3.69%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
2183 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
High shareholder yield

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Linical Co Ltd Company Profile

Linical Co., Ltd. provides drug development services primarily in the areas of oncology and central nervous system to pharmaceutical companies worldwide. The company offers drug development consulting services, such as market analysis of products in development, regulatory affairs consultation support, and licensing support. It also provides clinical research and development, and contract medical affairs services, including front-end services comprising project management, monitoring, quality control, vendor management, auditing, and clinical research secretariats; and back-end services, which include data management, bio statistical analysis, medical writing, pharmacovigilance, and medical management. The company was incorporated in 2005 and is headquartered in Osaka, Japan.

Employees
598
Market
Japan

Compare 2183 to Peers and Sector

Metrics to compare
2183
Peers
Sector
Relationship
P/E Ratio
−14.2x13.4x−0.5x
PEG Ratio
0.050.000.00
Price/Book
1.1x1.9x2.6x
Price / LTM Sales
0.7x3.1x3.3x
Upside (Analyst Target)
-8.5%43.5%
Fair Value Upside
Unlock4.6%6.9%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -23.86%
Dividend Yield
4.72%
Industry Median 2.60%
Annualised payout
16.00
Paid unevenly
5-Years Growth
+4.24%
Growth Streak

Earnings

Latest Release
May 15, 2025
EPS / Forecast
-9.84 / --
Revenue / Forecast
2.48B / 3.14B
EPS Revisions
Last 90 days

2183 Income Statement

FAQ

What Stock Exchange Does Linical Co Ltd Trade On?

Linical Co Ltd is listed and trades on the Tokyo Stock Exchange stock exchange.

What Is the Stock Symbol for Linical Co Ltd?

The stock symbol for Linical Co Ltd is "2183."

What Is the Linical Co Ltd Market Cap?

As of today, Linical Co Ltd market cap is 7.68B.

What Is Linical Co Ltd's Earnings Per Share (TTM)?

The Linical Co Ltd EPS (TTM) is -23.86.

When Is the Next Linical Co Ltd Earnings Date?

Linical Co Ltd will release its next earnings report on 13 Aug 2025.

From a Technical Analysis Perspective, Is 2183 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Linical Co Ltd Stock Split?

Linical Co Ltd has split 1 times.

How Many Employees Does Linical Co Ltd Have?

Linical Co Ltd has 598 employees.

What is the current trading status of Linical Co Ltd (2183)?

As of 07 Aug 2025, Linical Co Ltd (2183) is trading at a price of 339.00, with a previous close of 339.00. The stock has fluctuated within a day range of 338.00 to 340.00, while its 52-week range spans from 258.00 to 416.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.